United States Superficial Bladder Cancer Drugs Market Research Report Forecast 2017-2021

April 2017 | 113 pages | ID: U0D14337BD9EN
S&P Consulting

Abstracts

The United States Superficial Bladder Cancer Drugs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Superficial Bladder Cancer Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Superficial Bladder Cancer Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Altor BioScience Corporation
APIM Therapeutics AS
Bavarian Nordic A/S
Cold Genesys, Inc.
Spectrum Pharmaceuticals, Inc.
Telesta Therapeutics Inc.
UroGen Pharmaceuticals, Ltd.
Viventia Bio Inc.
endo pharmaceutical

United States Superficial Bladder Cancer Drugs Market: Product Segment Analysis
Type 1
Type 2
Type 3

United States Superficial Bladder Cancer Drugs Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 SUPERFICIAL BLADDER CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Superficial Bladder Cancer Drugs
1.2 Superficial Bladder Cancer Drugs Market Segmentation by Type
  1.2.1 United States Production Market Share of Superficial Bladder Cancer Drugs by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Superficial Bladder Cancer Drugs Market Segmentation by Application
  1.3.1 Superficial Bladder Cancer Drugs Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Superficial Bladder Cancer Drugs (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON SUPERFICIAL BLADDER CANCER DRUGS INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES SUPERFICIAL BLADDER CANCER DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 United States Superficial Bladder Cancer Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 United States Superficial Bladder Cancer Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Superficial Bladder Cancer Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Superficial Bladder Cancer Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Superficial Bladder Cancer Drugs Market Competitive Situation and Trends
  3.5.1 Superficial Bladder Cancer Drugs Market Concentration Rate
  3.5.2 Superficial Bladder Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES SUPERFICIAL BLADDER CANCER DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Superficial Bladder Cancer Drugs Production and Market Share by Type (2012-2017)
4.2 United States Superficial Bladder Cancer Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Superficial Bladder Cancer Drugs Price by Type (2012-2017)
4.4 United States Superficial Bladder Cancer Drugs Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES SUPERFICIAL BLADDER CANCER DRUGS MARKET ANALYSIS BY APPLICATION

5.1 United States Superficial Bladder Cancer Drugs Consumption and Market Share by Application (2012-2017)
5.2 United States Superficial Bladder Cancer Drugs Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES SUPERFICIAL BLADDER CANCER DRUGS MANUFACTURERS ANALYSIS

6.1 Altor BioScience Corporation
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 APIM Therapeutics AS
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Bavarian Nordic A/S
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Cold Genesys, Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Spectrum Pharmaceuticals, Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Telesta Therapeutics Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 UroGen Pharmaceuticals, Ltd.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Viventia Bio Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 endo pharmaceutical
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 SUPERFICIAL BLADDER CANCER DRUGS MANUFACTURING COST ANALYSIS

7.1 Superficial Bladder Cancer Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Superficial Bladder Cancer Drugs

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Superficial Bladder Cancer Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Superficial Bladder Cancer Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES SUPERFICIAL BLADDER CANCER DRUGS MARKET FORECAST (2017-2021)

11.1 United States Superficial Bladder Cancer Drugs Production, Revenue Forecast (2017-2021)
11.2 United States Superficial Bladder Cancer Drugs Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Superficial Bladder Cancer Drugs Production Forecast by Type (2017-2021)
11.4 United States Superficial Bladder Cancer Drugs Consumption Forecast by Application (2017-2021)
11.5 Superficial Bladder Cancer Drugs Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Superficial Bladder Cancer Drugs
Table Classification of Superficial Bladder Cancer Drugs
Figure United States Sales Market Share of Superficial Bladder Cancer Drugs by Type in 2015
Table Application of Superficial Bladder Cancer Drugs
Figure United States Sales Market Share of Superficial Bladder Cancer Drugs by Application in 2015
Figure United States Superficial Bladder Cancer Drugs Sales and Growth Rate (2011-2021)
Figure United States Superficial Bladder Cancer Drugs Revenue and Growth Rate (2011-2021)
Table United States Superficial Bladder Cancer Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Superficial Bladder Cancer Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Superficial Bladder Cancer Drugs Sales Share by Manufacturers
Figure 2016 Superficial Bladder Cancer Drugs Sales Share by Manufacturers
Table United States Superficial Bladder Cancer Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Superficial Bladder Cancer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Superficial Bladder Cancer Drugs Revenue Share by Manufacturers
Table 2016 United States Superficial Bladder Cancer Drugs Revenue Share by Manufacturers
Table United States Market Superficial Bladder Cancer Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Superficial Bladder Cancer Drugs Average Price of Key Manufacturers in 2015
Figure Superficial Bladder Cancer Drugs Market Share of Top 3 Manufacturers
Figure Superficial Bladder Cancer Drugs Market Share of Top 5 Manufacturers
Table United States Superficial Bladder Cancer Drugs Sales by Type (2012-2017)
Table United States Superficial Bladder Cancer Drugs Sales Share by Type (2012-2017)
Figure United States Superficial Bladder Cancer Drugs Sales Market Share by Type in 2015
Table United States Superficial Bladder Cancer Drugs Revenue and Market Share by Type (2012-2017)
Table United States Superficial Bladder Cancer Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Superficial Bladder Cancer Drugs by Type (2012-2017)
Table United States Superficial Bladder Cancer Drugs Price by Type (2012-2017)
Figure United States Superficial Bladder Cancer Drugs Sales Growth Rate by Type (2012-2017)
Table United States Superficial Bladder Cancer Drugs Sales by Application (2012-2017)
Table United States Superficial Bladder Cancer Drugs Sales Market Share by Application (2012-2017)
Figure United States Superficial Bladder Cancer Drugs Sales Market Share by Application in 2015
Table United States Superficial Bladder Cancer Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Superficial Bladder Cancer Drugs Sales Growth Rate by Application (2012-2017)
Table Altor BioScience Corporation Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Altor BioScience Corporation Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Altor BioScience Corporation Superficial Bladder Cancer Drugs Market Share (2012-2017)
Table APIM Therapeutics AS Basic Information, Manufacturing Base, Production Area and Its Competitors
Table APIM Therapeutics AS Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table APIM Therapeutics AS Superficial Bladder Cancer Drugs Market Share (2012-2017)
Table Bavarian Nordic A/S Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bavarian Nordic A/S Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Bavarian Nordic A/S Superficial Bladder Cancer Drugs Market Share (2012-2017)
Table Cold Genesys, Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Cold Genesys, Inc. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Cold Genesys, Inc. Superficial Bladder Cancer Drugs Market Share (2012-2017)
Table Spectrum Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Spectrum Pharmaceuticals, Inc. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Spectrum Pharmaceuticals, Inc. Superficial Bladder Cancer Drugs Market Share (2012-2017)
Table Telesta Therapeutics Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Telesta Therapeutics Inc. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Telesta Therapeutics Inc. Superficial Bladder Cancer Drugs Market Share (2012-2017)
Table UroGen Pharmaceuticals, Ltd. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table UroGen Pharmaceuticals, Ltd. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table UroGen Pharmaceuticals, Ltd. Superficial Bladder Cancer Drugs Market Share (2012-2017)
Table Viventia Bio Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Viventia Bio Inc. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Viventia Bio Inc. Superficial Bladder Cancer Drugs Market Share (2012-2017)
Table endo pharmaceutical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table endo pharmaceutical Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table endo pharmaceutical Superficial Bladder Cancer Drugs Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Superficial Bladder Cancer Drugs
Figure Manufacturing Process Analysis of Superficial Bladder Cancer Drugs
Figure Superficial Bladder Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Superficial Bladder Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Superficial Bladder Cancer Drugs
Table Distributors/Traders List
Figure United States Superficial Bladder Cancer Drugs Production and Growth Rate Forecast (2017-2021)
Figure United States Superficial Bladder Cancer Drugs Revenue and Growth Rate Forecast (2017-2021)
Table United States Superficial Bladder Cancer Drugs Production Forecast by Type (2017-2021)
Table United States Superficial Bladder Cancer Drugs Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Altor BioScience Corporation
APIM Therapeutics AS
Bavarian Nordic A/S
Cold Genesys, Inc.
Spectrum Pharmaceuticals, Inc.
Telesta Therapeutics Inc.
UroGen Pharmaceuticals, Ltd.
Viventia Bio Inc.
endo pharmaceutical
SANOFI